Oncolytic adenovirus improves anti-tumor efficacy of adoptive T cell therapy by breaking tumor-induced immunosuppression and peripheral tolerance
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P315
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tähtinen, Siri
Grönberg-Vähä-Koskela, Susanna
Lumen, Dave
Merisalo-Soikkeli, Maiju
Siurala, Mikko
Airaksinen, Anu J
Vähä-Koskela, Markus
Hemminki, Akseli
Article History
First Online: 4 November 2015